| | Infection After Total Shoulder ArthroplastyInfection of shoulder arthroplasties is a relatively rare (0.5%) but potentially devastating complication. Treatment includes resection arthroplasty, debridement and prosthetic retention, immediate exchange arthroplasty, and staged-exchange arthroplasty. To date, the most reliable treatment is staged-exchange arthroplasty. Debridement and prosthetic retention can be considered with infections detected within 3 weeks of onset, well-fixed components, no signs of osteomyelitis, and if the infecting organism is not staph epidermidis. Staged-exchange arthroplasty involves complete removal of all components, and placement of an anatomic antibiotic-impregnated cement spacer. Results can still be quite good for pain relief after reimplantation. Functional outcome has been variable in the past but may be improved significantly with the use of the reverse implant. Infection after arthroplasty of the shoulder is a difficult clinical problem that can be challenging to diagnose and treat. There are instances when the diagnosis of infection is explicit, as when there is a draining sinus. However, more commonly infection occurs in an occult fashion and requires a high degree of clinical suspicion. The rate of infection occurring in total shoulder arthroplasty has been historically low with reported rates of approximately 2% in primary shoulder arthroplasty and 4% in revision cases.1 This is comparable to studies involving total hip arthroplasty that have reported infection rates of around 1% in primary hip arthroplasty and 3% in revisions.2, 3, 4 Despite a low overall incidence of infection the clinical implications can be significant, leading to increased patient morbidity and prolonged medical and surgical management. Pathogens  The most common pathogens associated with shoulder arthroplasty infections are Gram-positive bacteria. The most common organisms are Staphylococcus aureus, Staphylococcus epidermidis, and Propionibacterium acnes.5 The infecting organism has clinical and prognostic significance regarding both treatment and success. S. aureus is a Gram-positive bacterium that often requires treatment with beta lactamase–resistant penicillin such as nafcillin. S. aureus, because of the increasing prevalence of methicillin-resistant strains, frequently requires treatment with vancomycin. While S. aureus is often antibiotic resistant, it does not usually produce a significant glycocalyx. This lack of a significant glycocalyx allows improved antibiotic penetrance and can allow successful treatment of infection despite implant retention. While infection with S. aureus is the most common, it also has a good prognosis for eradication of the infection. Staphylococcus epidermidis is a Gram-positive, coagulase negative cocci and is highly antibiotic resistant. S. epidermidis, unlike S. aureus, is particularly adept in producing a robust glycocalyx. The formation of this glycocalyx makes S. epidermidis especially difficult to eradicate in infections around implants.6, 7 The presence of glycocalyx-producing bacteria significantly reduces the efficacy of parenterally administered antibiotics.6, 7 For this reason we recommend that prosthetic infections involving S. epidermidis be treated with implant explantation.8 Propionibacterium acnes has become a well-recognized pathogen in the infection of shoulder arthroplasty. Propionibacterium is an anaerobic Gram-positive rod that is part of the normal skin flora. P. acnes remains very antibiotic susceptible despite the emergence of some tetracycline-resistant strains. Infection Diagnosis  Making the diagnosis of infection in the face of a total joint arthroplasty can be challenging and is critical for prompt initiation of treatment. The risk factors that are associated with increased infection rates include revision surgery, systemic steroid use, immunosuppression, multiple steroid injections, and radiation therapy.5 The gold standard for diagnosis of infection is two positive cultures obtained at different time intervals that exhibit the same organism. Unfortunately, this scenario is not common and diagnosis is frequently made with the combination of a positive culture along with clinical suspicion. The use of a positive culture alone to dictate treatment should be undertaken with prudence because of the significant implications of a false-positive result. When taking intraoperative specimens it is important to take a negative control to facilitate interpretation of a positive culture. A negative control can be performed by opening a culture set in the operating room, waving it in the air, and sending it to the laboratory. In this way, the interpretation of a positive culture can be compared with a negative control, thus avoiding a potentially long, protracted, and possibly unnecessary treatment course. Early signs of clinical infection include pain and swelling surrounding the shoulder. Erythema and purulent drainage often manifest as later signs of infection. In contrast, constitutional signs, including fever and malaise, are often rare presentations of upper extremity infections. Laboratory markers for infection include the use of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and white blood cell count (WBC). These laboratory results are nonspecific but are useful in contributing to the overall clinical picture and monitoring the response to treatment. The hip arthroplasty literature has support for using ESR and CRP in following treatment, with a normal ESR and CRP being 100% specific for ruling out infection.9 CRP will normalize to less than 3.0 after 3 weeks while ESR may remain elevated for as long as 6 months.10 Unlike ESR and CRP, the leukocyte count has been shown to be unreliable in the detection of infection, with elevated counts in only 15 to 20% of patients.11, 12 The use of aspiration can be an important piece of armamentarium in the diagnosis of total joint infections, but it must be used prudently. The use of preoperative aspirations is particularly helpful and provides a control sample to intraoperative cultures that are subsequently obtained. A consistent organism between two different time points adds significant reliability to the diagnosis of infection and can help to guide antibiotic therapy. While aspiration can be a helpful adjunct, there can be a high false-negative rate that has been reported to be as high as 50% in the series by Coste and colleagues.1, 5 Radiographic signs of infection include radiolucency surrounding the implant–cement or cement–bone interface. While a radiolucent line is not an uncommon occurrence after shoulder arthroplasty, serial radiographs can show a progression of radiolucency. Loosening of the implant, including subsidence or change in implant positioning, is another radiographic marker for infection. While aseptic loosening of an implant is possible, it is uncommon in the early postoperative period. The use of adjunctive radiologic modalities such as technetium and indium-111 scans can contribute to diagnosis. Indium-111 scans have been shown to be more sensitive than technetium scans and have the added ability to differentiate between septic and aseptic loosening.13 Infection Treatment  Treatment of the infected total arthroplasty of the upper extremity includes both operative and nonoperative treatments. Nonoperative treatment, including the use of suppressive antibiotics, is primarily reserved for patients who are too sick to undergo an operative procedure and who are infected with an organism with low virulence. Operative treatment includes irrigation and debridement along with retention of the prosthesis, as well as single- and two-stage reimplantations. Resection arthroplasty is an option that gives patients a high success rate of eradicating the infection. Unfortunately, resection arthroplasty has also been associated with unreliable pain relief, a high complication rate, and poor functional outcomes.5, 14 Sperling and colleagues5, 14 have reported a 50% complication rate after resection arthroplasty, including a fracture in 6 of 21 patients. In the same study, however, they also demonstrated no reoperations due to persistent infection. Irrigation and debridement with retention of the prosthesis can be considered in an acute infection less than 3 weeks old with absence of prosthetic loosening. Sperling and colleagues5 showed a 50% failure rate with this treatment, resulting in continuing infection. In our experience, cases involving S. epidermidis have a poor success rate using this method and we recommend against implant retention unless medically unfeasible.8 While a single-stage reimplantation can be performed, it is usually reserved for patients with significant medical comorbidities that would preclude a second operative procedure. A two-staged reimplantation is the preferred method for treating an infected arthroplasty of the upper extremity.5, 15, 16 The use of a staged reimplantation of shoulder arthroplasties has been demonstrated to show a low recurrence rate of infection (Fig. 1).14, 16 It has also been shown to have superior functional outcomes to a resection arthroplasty.5, 14 These patients, while faring better than with other treatment options, do not typically attain the same preoperative functional level.15 A thorough debridement, including removal of all cement, is performed. The complete removal of the cement is extremely important and can be facilitated with the use of an ultrasound extraction device. After removal of the cement, a complete synovectomy is necessary. A cement spacer can then be fabricated and used until the delayed reimplantation can be performed. The previous implant is used as a template and a cement spacer with the same dimensions is made. The purpose of the anatomic antibiotic spacer is to provide high local concentrations of antibiotics that are not attainable intravenously. The spacer also acts to prevent contracture formation and to maintain the length of the rotator cuff. If the patient is unable to undergo a second operation, an anatomic spacer can also allow a more functional joint. Explantation is followed by 6 weeks of appropriate antibiotics. After the completion of antibiotics, reimplantation is performed utilizing a hemiarthroplasty, total shoulder arthroplasty, or reverse total shoulder (Fig. 2). When multiple debridements in the face of infection have been performed, the rotator cuff is often deficient. In these patients, the advent of the reverse total shoulder arthroplasty can be a good option. Clinical outcome studies are needed to investigate this application. Summary  Infection after arthroplasty of the upper extremity is a difficult clinical problem to undertake. However, many patients can do well after a staged reconstruction with low recurrence of infection and good functional results. While rapid diagnosis and treatment is important, the avoidance of a false positive is equally imperative. Good clinical judgment along with appropriate ancillary tests can contribute to reliable diagnosis and prudent treatment. References  1. 1Coste JS, Reig S, Trojani C, et al. The management of infection in arthroplasty of the shoulder. J Bone Joint Surg Br. 2004;86:65–69. 2. 2Blom AW, Taylor AH, Pattison G, et al. Infection after total hip arthroplasty: the Avon experience. J Bone Joint Surg Br. 2003;85:956–959.
CrossRef
3. 3Ure KJ, Amstutz HC, Nasser S, et al. Direct-exchange arthroplasty for the treatment of infection after total hip replacement: an average ten-year follow-up. J Bone Joint Surg Am. 1998;80:961–968. MEDLINE 4. 4Lentino JR. Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists. Clin Infect Dis. 2003;36:1157–1161.
CrossRef
5. 5Sperling JW, Kozako TK, Hassen AD, et al. Infection after shoulder arthroplastys. Clin Orthop. 2001;382:206–216.
CrossRef
6. 6Nishimura S, Tsurumoto T, Yonekura A, et al. Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus epidermidis biofilms isolated from infected total hip arthroplasty cases. J Orthop Sci. 2006;11:46–50. MEDLINE |
CrossRef
7. 7Gristina AG, Costerton JW. Bacterial adherence to biomaterials and tissue: the significance of its role in clinical sepsis. J Bone Joint Surg Am. 1985;67:264–273. MEDLINE 8. 8Yamaguchi K, Adams RA, Morrey BF. Infection after total elbow arthroplasty. J Bone Joint Surg Am. 1998;80:481–491. MEDLINE 9. 9Duffy PJ, Masri BA, Garbuz DS, et al. Evaluation of patients with pain following total hip replacement. J Bone Joint Surg Am. 2005;87:2566–2575. MEDLINE 10. 10Schmalzried TP. The infected hip: telltale signs and treatment options. J Arthroplasty. 2006;21:97–100. Abstract | Full Text |
Full-Text PDF (55 KB)
|
CrossRef
11. 11Canner GC, Steinberg ME, Heppenstall RB, et al. The infected hip after total hip arthroplasty. J Bone Joint Surg Am. 1984;66:1393–1399. MEDLINE 12. 12Spangehl MJ, Masri BA, O’Connell JX, et al. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am. 1999;81:672–683. MEDLINE 13. 13Merkel KD, Brown ML, Dewanjee MK, et al. Comparison of indium-labeled-leukocyte imaging with sequential technetium–gallium scanning in the diagnosis of low-grade musculoskeletal sepsis: a prospective study. J Bone Joint Surg Am. 1985;67:465–476. MEDLINE 14. 14Mileti J, Sperling JW, Cofield RH. Reimplantation of a shoulder arthroplasty after a previous infected arthroplasty. J Shoulder Elbow Surg. 2004;13:528–531. Abstract | Full Text |
Full-Text PDF (125 KB)
|
CrossRef
15. 15Dines JS, Fealy S, Strauss EJ, et al. Outcomes analysis of revision total shoulder replacement. J Bone Joint Surg Am. 2006;88:1494–1500. MEDLINE |
CrossRef
16. 16Seitz WH, Damacen H. Staged exchange arthroplasty for shoulder sepsis. J Arthroplasty. 2002;17:36–40. Abstract |
Full-Text PDF (366 KB)
|
CrossRef
Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, MO. Address reprint requests to Ken Yamaguchi, MD, Department of Orthopaedic Surgery, Washington University School of Medicine, Suite 11300 West Pavilion, One Barnes-Jewish Hospital Plaza, St. Louis, MO 63110.
PII: S1045-4527(06)00079-4 doi:10.1053/j.sart.2006.11.014 © 2007 Elsevier Inc. All rights reserved. | |
|